pI: 8.6981 |
Length (AA): 1099 |
MW (Da): 130702 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
278 | 515 | 4dkj (A) | 89 | 332 | 29.00 | 0.49 | 0.42 | 0.114161 | 2.26 |
668 | 1017 | 3crv (A) | 237 | 541 | 26.00 | 0.00041 | 1 | 0.346071 | 1.04 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, late trophozoite, Oocyst, Sporozoite, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, early schizont, early trophozoite. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Ring. | Zanghi G |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_127999)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G79890 | RAD3-like DNA-binding helicase protein |
Babesia bovis | BBOV_I004620 | DNA repair helicase (rad3) and DEAD_2 domain containing protein |
Brugia malayi | Bm1_22935 | helicase |
Candida albicans | CaO19.2000 | chromosome transmission |
Candida albicans | CaO19.9551 | chromosome transmission |
Caenorhabditis elegans | CELE_M03C11.2 | Protein CHL-1 |
Cryptosporidium hominis | Chro.70391 | helicase |
Cryptosporidium parvum | cgd7_3510 | helicase, putative |
Drosophila melanogaster | Dmel_CG11403 | CG11403 gene product from transcript CG11403-RA |
Echinococcus granulosus | EgrG_000856200 | ATP dependent RNA helicase DDX11 |
Echinococcus multilocularis | EmuJ_000856200 | ATP dependent RNA helicase DDX11 |
Giardia lamblia | GL50803_92673 | CHL1-like protein |
Homo sapiens | ENSG00000013573 | DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 |
Homo sapiens | 102725121 | putative ATP-dependent RNA helicase DDX12-like |
Leishmania braziliensis | LbrM.03.0500 | DNA repair helicase, putative |
Leishmania braziliensis | LbrM.15.1330 | DNA repair helicase, putative |
Leishmania donovani | LdBPK_030570.1 | DNA repair helicase, putative |
Leishmania infantum | LinJ.03.0570 | DNA repair helicase, putative |
Leishmania major | LmjF.03.0590 | DNA repair helicase, putative |
Leishmania mexicana | LmxM.03.0590 | DNA repair helicase, putative |
Loa Loa (eye worm) | LOAG_14466 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10580 | helicase |
Mus musculus | ENSMUSG00000035842 | DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 |
Oryza sativa | 9272109 | Os05g0219800 |
Plasmodium berghei | PBANKA_1339700 | DEAD box helicase, putative |
Plasmodium falciparum | PF3D7_1324500 | DEAD box helicase, putative |
Plasmodium knowlesi | PKNH_1204300 | DEAD box helicase, putative |
Plasmodium vivax | PVX_116650 | DEAD box helicase, putative |
Plasmodium yoelii | PY00821 | 55525-51977 |
Saccharomyces cerevisiae | YPL008W | Chl1p |
Schistosoma japonicum | Sjp_0093110 | ko:K01509 adenosinetriphosphatase [EC3.6.1.3], putative |
Schistosoma mansoni | Smp_101300 | chl1 helicase homolog |
Schistosoma mansoni | Smp_130210 | chl1 helicase homolog |
Schmidtea mediterranea | mk4.008719.01 | Probable ATP-dependent RNA helicase DDX11 |
Schmidtea mediterranea | mk4.008719.00 | Probable ATP-dependent RNA helicase DDX11 |
Schmidtea mediterranea | mk4.023131.00 | Probable ATP-dependent RNA helicase DDX11 |
Trypanosoma brucei gambiense | Tbg972.10.4420 | DNA repair helicase, putative |
Trypanosoma brucei | Tb927.10.3550 | DNA repair helicase, putative |
Trypanosoma congolense | TcIL3000_10_2960 | DNA repair helicase, putative |
Trypanosoma cruzi | TcCLB.510311.130 | DNA repair helicase, putative |
Trypanosoma cruzi | TcCLB.508153.1120 | DNA repair helicase, putative |
Toxoplasma gondii | TGME49_227630 | hypothetical protein |
Theileria parva | TP03_0644 | DNA helicase, putative |
Trichomonas vaginalis | TVAG_373000 | regulator of telomere elongation helicase 1 rtel1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.3550 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.3550 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.3550 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.3550 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_M03C11.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.1